Clinically-Relevant Weight Loss is Achieved Independently of Early Weight Loss Response to Once-Weekly Subcutaneous Semaglutide 2.4 MG (STEP 4)
This is not a subtle difference
It is not intended for human or animal consumption, diagnostic use, therapeutic use, clinical use, food use, cosmetic use, or household use
Take the first step toward a healthier, happier, slimmer, and more energized, you
For this reason, Matthews advises patients using GLP-1 medications to focus on high-quality protein at every meal, combined with vegetables and fiber-rich foods that help support digestion and prevent constipation, a common side effect of the drugs
Talk to your doctor before changing your dosage or stopping the medication